MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hep.0000000000000895

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2024

Ultrasound-based steatosis grading system using 2D-attenuation imaging: An individual patient data meta-analysis with external validation.

Hobeika Christian, Ronot Maxime, Guiu Boris, Ferraioli Giovanna, Iijima Hiroko, Tada Toshifumi, Lee Dong Ho, Kuroda Hidekatsu, Lee Young Hwan, Lee Jeong Min, Kim So Yeon, Cassinotto Christophe, Maiocchi Laura, Raimondi Ambra, Nishimura Takashi, Kumada Takashi, Kwon Eun Young, Jang Jong Keon, Correas Jean-Michel, Valla Dominique, Vilgrain Valérie, Dioguardi Burgio Marco

СтатьяМетаанализСистематический обзорПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Noninvasive tools assessing steatosis, such as ultrasonography-based 2D-attenuation imaging (ATI), are needed to tackle the worldwide burden of steatotic liver disease. This one-stage individual patient data (IPD) meta-analysis aimed to create an ATI-based steatosis grading system.

APPROACH AND

RESULTS

A systematic review (EMBASE + MEDLINE, 2018-2022) identified studies, including patients with histologically or magnetic resonance imaging proton-density fat fraction (MRI-PDFF)-verified ATI for grading steatosis (S0 to S3). One-stage IPD meta-analyses were conducted using generalized mixed models with a random study-specific intercept. Created ATI-based steatosis grading system (aS0 to aS3) was externally validated on a prospective cohort of patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (n=174, histologically and MRI-PDFF-verified steatosis). Eleven enrolled studies included 1374 patients, classified into S0, S1, S2, and S3 in 45.4%, 35.0%, 9.3%, and 10.3% of the cases. ATI was correlated with histological steatosis ( r = 0.60; 95% CI: 0.52, 0.67; p < 0.001) and MRI-PDFF ( r = 0.70; 95% CI: 0.66, 0.73; p < 0.001) but not with liver stiffness ( r = 0.03; 95% CI: -0.04, 0.11, p = 0.343). Steatosis grade was an independent factor associated with ATI (coefficient: 0.24; 95% CI: [0.22, 0.26]; p < 0.001). ATI marginal means within S0, S1, S2, and S3 subpopulations were 0.59 (95% CI: [0.58, 0.61]), 0.69 (95% CI [0.67, 0.71]), 0.78 (95% CI: [0.76, 0.81]), and 0.85 (95% CI: [0.83, 0.88]) dB/cm/MHz; all contrasts between grades were significant ( p < 0.0001). Three ATI thresholds were calibrated to create a new ATI-based steatosis grading system (aS0 to aS3, cutoffs: 0.66, 0.73, and 0.81 dB/cm/MHz). Its external validation showed Obuchowski measures of 0.84 ± 0.02 and 0.82 ± 0.02 with histologically based and MRI-PDFF-based references.

CONCLUSIONS

ATI is a reliable, noninvasive marker of steatosis. This validated ATI-based steatosis grading system could be valuable in assessing patients with metabolic dysfunction-associated steatotic liver disease.

Для цитирования: Hobeika Christian, Ronot Maxime, Guiu Boris, Ferraioli Giovanna, Iijima Hiroko, Tada Toshifumi, Lee Dong Ho, Kuroda Hidekatsu, Lee Young Hwan, Lee Jeong Min, Kim So Yeon, Cassinotto Christophe, Maiocchi Laura, Raimondi Ambra, Nishimura Takashi, Kumada Takashi, Kwon Eun Young, Jang Jong Keon, Correas Jean-Michel, Valla Dominique, Vilgrain Valérie, Dioguardi Burgio Marco. Ultrasound-based steatosis grading system using 2D-attenuation imaging: An individual patient data meta-analysis with external validation.. Hepatology (Baltimore, Md.). 2024. DOI: 10.1097/hep.0000000000000895.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.